NS Healthcare is using cookies
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
White Paper
January 27, 2016
The arrival of personalised medicine has enabled pharmaceutical companies to reinvent their business model. Clinical Trials Insight speaks to Dr Claire Huguet at Randox Biosciences about how companion diagnostics (CDx) are becoming a significant proportion of Randox’s diagnostic pipeline, and the tailored technology and support that the company can provide.
Download to find out more.